Skip to main content
. 2020 Jul 20;10:11997. doi: 10.1038/s41598-020-68829-y

Figure 1.

Figure 1

Mps1 expression correlates with aggressive tumors and predicts clinical outcome in neuroblastoma patients. (AE) Box plots of Mps1 expression relative to tumor stage (A), risk classification (B), tumor progression (C), death from the tumor (D) and MYCN status (E). (F,G) Kaplan–Meier curves reporting patient’s event-free survival (F) and overall survival (G) probability with respect to Mp1 expression.